Snapshot · The Peter Attia Drive
About 10% of the population carry gene variants that make the CYP2C19 enzyme completely nonfunctional, meaning their bodies cannot activate the antiplatelet drug Plavix.
Where this was said
At 39:03 · chapter starts 38:45
Pharmacogenetics is where Peter's tone shifts from skepticism to genuine enthusiasm. Instead of trying to predict which disease someone will develop in a probabilistic and often non-actionable way, pharmacogenetics asks a far narrower and more tractable question: how will this specific patient respond to this specific drug? Genetics performs far better when the question is that specific [1] — Peter Attia "Pharmacogenetics sidesteps the uncertainty of disease prediction and asks a far more tractable question: how will you respond to this speci…" 37:50 . The Plavix/CYP2C19 example is compelling: about 10% of the population carry CYP2C19 loss-of-function variants that prevent their bodies from activating the antiplatelet drug, meaning that after a stent or vascular event, a pharmacogenetic test could redirect them to an alternative drug that does work. The allopurinol/HLA-B58 example is perhaps even more striking: HLA-B58 carriers face a substantially elevated risk of a potentially life-threatening hypersensitivity reaction to allopurinol, a widely prescribed gout medication. Testing for HLA-B58 before prescribing allopurinol has become standard of care in Peter's practice. Pharmacogenetics does not always dictate the final answer, but it informs it — and that more modest, more defensible claim is precisely what makes it so valuable relative to the broader promises of the genetic marketplace.
Plot genetic tests on two axes: how large is the variant's effect on risk, and how much does knowing about it change what you do clinically? BRCA sits upper right (high effect, high actionability). MTHFR sits lower left. Most tests fall somewhere in between, and the two dimensions don't always move together.
Spencer Greenberg and Jeremy Stevenson analyzed almost 500 self-improvement techniques and found they all reduce to just 12 underlying psychological drivers.
Cold exposure has good short-term alertness benefits but the evidence base for long-term health benefits is much weaker than popularly believed.
In a randomized study of 20 habit-formation techniques run on hundreds of people, almost none of the techniques produced statistically meaningful results.
People given a tiny-habit fallback option (e.g. 10 squats instead of gym) were actually MORE successful at completing the full habit, not less.
The most effective habit-formation technique was 'habit reflection' — recalling a past successful habit, writing down what helped, then applying those lessons to a new habit.
A study found that simply scheduling enjoyable activities was as effective as standard cognitive behavioral therapy for depression, leading to its own therapy called behavioral activation.
The 'worry time' technique — deferring all worries to a designated time of day — helps people realize they have more control over worry than they thought and reveals it is less useful than it feels.
A study found that participants told to try to stay awake while in bed fell asleep faster than participants told to try to sleep — illustrating the paradox of direct effort.
Spencer Greenberg reduced his severe social anxiety dramatically in roughly 6 months through a structured exposure therapy hierarchy, culminating in asking strangers for hugs.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.